The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study.
Saved in:
| Title: | The potential adverse effects of hypodermic glucagon‐like peptide ‐1 receptor agonist on patients with type 2 diabetes: A population‐based study. |
|---|---|
| Authors: | Cheng, Zhiyuan1,2 (AUTHOR), Wang, Shuang3 (AUTHOR), Li, Fu‐rong1,2 (AUTHOR), Jin, Cheng1,2 (AUTHOR), Mo, Chunbao1,2 (AUTHOR), Zheng, Jing3 (AUTHOR), Li, Xia1,2,4 (AUTHOR), Liang, Fengchao1,2,4 (AUTHOR) liangfc@sustech.edu.cn, Yang, Jinkui5 (AUTHOR), Gu, Dongfeng1,2,4 (AUTHOR) gudf@sustech.edu.cn |
| Source: | Journal of Diabetes. Oct2024, Vol. 16 Issue 10, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
